文献速递乳腺癌放疗放疗物理与技术

接受放疗的乳腺癌患者心脏传导系统暴露及其与心脏和心腔剂量的关联

Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses.
PubMed 文献 · Clin Transl Radiat Oncol · 2022-11-04

该单中心研究基于2009至2013年116例接受三维适形放疗(3D-CRT)的乳腺癌患者(左侧56例、右侧60例),评估窦房结(SAN)和房室结(AVN)剂量,并检验全心脏和四个心腔能否作为其替代指标。结果显示左侧乳腺癌患者SAN和AVN平均剂量分别为0.47±0.24 Gy和0.74±0.29 Gy,右侧患者SAN平均剂量为1.57±0.63 Gy且超过85%患者SAN剂量>1 Gy;右心房是SAN剂量的较好替代指标(R²>0.80)。

要点

  • 右侧乳腺癌患者SAN平均剂量为1.57±0.63 Gy,超过85%患者SAN剂量>1 Gy。
  • 左侧乳腺癌患者心脏、SAN和AVN平均剂量分别为3.60±2.28 Gy、0.47±0.24 Gy和0.74±0.29 Gy。
  • 右心房是SAN剂量的较好替代指标(R²>0.80),但右侧乳腺癌中无大心脏结构可作为AVN的 relevant 替代指标(所有R²<0.70)。

核心结论

  • 在10年前接受3D-CRT的乳腺癌患者中,SAN和AVN暴露为中等程度,但许多未包含内乳淋巴结(IMN)的右侧患者SAN剂量可超过1 Gy。
  • 右心房似乎是SAN暴露的有趣替代指标;使用现代放疗技术时,仍需要对特定传导节点进行勾画。

研究设计与样本

  • 单中心研究,基于2009至2013年116例接受3D-CRT的乳腺癌患者(左侧56例,右侧60例),未采用呼吸门控策略且极少IMN照射。
  • 心脏、左心室(LV)、右心室(RV)、左心房(LA)和右心房(RA)使用多图谱自动分割勾画;SAN和AVN使用特定图谱手动勾画。
  • 基于回归分析估计决定系数(R²),以评估大心脏结构是否为SAN和AVN剂量的相关替代指标(R²>0.70)。

主要发现

  • 左侧乳腺癌:心脏平均剂量3.60±2.28 Gy,SAN平均剂量0.47±0.24 Gy,AVN平均剂量0.74±0.29 Gy。
  • 右侧乳腺癌:心脏平均剂量0.60±0.25 Gy,SAN平均剂量1.57±0.63 Gy(>85%患者SAN剂量>1 Gy),AVN平均剂量0.51±0.14 Gy。
  • 在所有大心脏结构中,RA是SAN剂量的最佳替代指标(R²>0.80)。
  • 对于AVN剂量,RA在左侧乳腺癌中也可能是有趣的替代指标(R²=0.78),但右侧乳腺癌中无大心脏结构为相关替代指标(所有R²<0.70),除外IMN患者中LA(R²=0.83)。

关键数值与推荐

  • 替代指标相关性阈值定义为R²>0.70。
  • 左侧乳腺癌患者SAN平均剂量0.47±0.24 Gy,AVN平均剂量0.74±0.29 Gy。
  • 右侧乳腺癌患者SAN平均剂量1.57±0.63 Gy,>85%患者SAN剂量>1 Gy。
  • RA对SAN剂量的R²>0.80;RA对左侧乳腺癌AVN剂量的R²=0.78;LA对IMN患者AVN剂量的R²=0.83。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess sinoatrial node (SAN) and atrioventricular node (AVN) doses for breast cancer (BC) patients treated with 3D-CRT and evaluate whether "large" cardiac structures (whole heart and four cardiac chambers) would be relevant surrogates. MATERIAL AND METHODS: This single center study was based on 116 BCE patients (56 left-sided, 60 right-sided) treated with 3D-CRT without respiratory gating strategies and few IMN irradiations from 2009 to 2013. The heart, the left and right ventricles (LV, RV), the left and right atria (LA, RA) were contoured using multi-atlases for auto-segmentation. The SAN and the AVN were manually delineated using a specific atlas. Based on regression analysis, the coefficients of determination (R2) were estimated to evaluate whether "large" cardiac structures were relevant surrogates (R2 > 0.70) of SAN and AVN doses. RESULTS: For left-sided BC, mean doses were: 3.60 ± 2.28 Gy for heart, 0.47 ± 0.24 Gy for SAN and 0.74 ± 0.29 Gy for AVN. For right-sided BC, mean heart dose was 0.60 ± 0.25 Gy, mean SAN dose was 1.57 ± 0.63 Gy (>85 % of patients with SAN doses > 1 Gy) and mean AVN dose was 0.51 ± 0.14 Gy. Among all "large" cardiac structures, RA appeared as the best surrogate for SAN doses (R2 > 0.80). Regarding AVN doses, the RA may also be an interesting surrogate for left-sided BC (R2 = 0.78), but none of "large" cardiac structures appeared as relevant surrogates among right-sided BC (all R2 < 0.70), except the LA for patients with IMN (R2 = 0.83). CONCLUSIONS: In BC patients treated 10 years ago with 3D-CRT, SAN and AVN exposure was moderate but could exceed 1 Gy to the SAN in many right-sided patients with no IMN-inclusion. The RA appeared as an interesting surrogate for SAN exposure. Specific conduction nodes delineation remains necessary by using modern radiotherapy techniques.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Errahmani MY, Locquet M, Broggio D, et al. Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses. Clin Transl Radiat Oncol. 2022. PMID: 36388244. doi:10.1016/j.ctro.2022.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。